Optimising future cervical screening strategies.

Area of Science:

• Oncology
• Virology
• Public Health

Background:

• Cervical cancer screening is transitioning from cytology to primary high-risk human papillomavirus (HR-HPV) testing.
• This shift aims to enhance screening sensitivity and extend screening intervals, potentially saving lives.

Purpose of the Study:

• To evaluate strategies for optimizing cervical cancer screening using primary HR-HPV testing.
• To address the challenge of HR-HPV testing's lower specificity and its implications for patient management.

Main Methods:

• Implementing early recall for women who test HR-HPV positive but have negative cytology.
• Considering the impact of prophylactic HPV vaccination on long-term screening frequency and cost-effectiveness.
• Exploring the potential of self-sampling for increased screening uptake and convenience.

Main Results:

• Primary HR-HPV testing offers increased sensitivity for detecting cervical cancer precursors.
• Early recall strategies can help manage false positives by identifying women who clear the virus.
• Vaccination combined with HR-HPV testing presents a future where cervical cancer could be rare.

Conclusions:

• Efficient strategies are crucial for integrating HR-HPV testing and vaccination in cervical cancer prevention.
• Optimizing screening protocols is necessary to maximize the benefits of new testing technologies and vaccination programs.